Who sells what? Country specific differences in substance availability on the Agora cryptomarket

International Journal of Drug Policy

Volumn 35, Issue , 2016, Pages 16-23

  Van Buskirk, Joe ^a   Naicker, Sundresan ^a   Roxburgh, Amanda ^a   Bruno, Raimondo ^b   Burns, Lucinda ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Cryptomarkets; New psychoactive substances; New technologies

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; CANNABINOID; CANNABIS; COCAINE; ILLICIT DRUG; KETAMINE; METHAMPHETAMINE; OPIATE; PERFORMANCE ENHANCING SUBSTANCE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; STREET DRUG;

ARTICLE; AUSTRALIA; CHINA; CONTROLLED STUDY; DRUG TRAFFIC; GEOGRAPHY; NETHERLANDS; PRIORITY JOURNAL; PROFIT; UNITED KINGDOM; UNITED STATES; COMMERCIAL PHENOMENA; DRUG DEPENDENCE; ECONOMICS; HUMAN; INTERNET; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION;

COMMERCE; DRUG TRAFFICKING; HUMANS; INTERNET; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84989902366     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2016.07.004     Document Type: Article

References (53)

1. Aldridge, J., Décary-Hétu, D., Not an ‘Ebay for Drugs’: The Cryptomarket ‘Silk Road’ as a Paradigm Shifting Criminal Innovation. 2014 Retrieved 24th of June, 2015, from http://ssrn.com/abstract=2436643.
2. Aldridge, J., Décary-Hétu, D., Hidden Wholesale: The drug diffusing capacity of online drug cryptomarkets. International Journal of Drug Policy 35 (2016), 7–15.
3. Australian Crime Commission (2014). 2013–2014 Illicit drug data report, Illicit drug data report. Canberra, Australia.
4. Australian Institute of Health and Welfare, National drug strategy household survey detailed report 2013. Drug statistics series no. 28. Cat. no. PHE 183., 2014, AIHW, Canberra.
5. Bancroft, A., Scott Reid, P., Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge. International Journal of Drug Policy, 2015, 10.1016/j.drugpo.2015.11.008.
6. Barratt, M.J., Silk Road: Ebay for drugs. Addiction, 107(3), 2012, 683, 10.1111/j.1360-0443.2011.03709.x.
7. Barratt, M.J., Ferris, J., Winstock, A.R., Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction 109:5 (2014), 774–783, 10.1111/add.12470.
8. Barratt, M.J., Ferris, J., Winstock, A.R., Safer scoring? Cryptomarkets, social supply and drug market violence. International Journal of Drug Policy 35 (2016), 24–31.
9. Boyer, E.W., Shannon, M., Hibberd, P.L., The Internet and psychoactive substance use among innovative drug users. Pediatrics 115:2 (2005), 302–305, 10.1542/peds.2004-1199.
10. Branwen, G., TOR black-market-related arrests. 2015 Retrieved 16th of November, 2015, from http://www.gwern.net/Black-market%20arrests.
11. Burns, L., Roxburgh, A., Bruno, R., Van Buskirk, J., Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia. Drug Testing and Analysis 6:7–8 (2014), 840–845, 10.1002/dta.1613.
12. Caulkins, J.P., Price and purity analysis for illicit drug: Data and conceptual issues. Drug and Alcohol Dependence 90:Suppl. 1 (2007), S61–S68, 10.1016/j.drugalcdep.2006.08.014.
13. Chandler, R.K., Fletcher, B.W., Volkow, N.D., Treating drug abuse and addiction in the criminal justice system: Improving public health and safety. JAMA 301:2 (2009), 183–190, 10.1001/jama.2008.976.
14. Chatwin, C., Mixed messages from Europe on drug policy reform: The cases of Sweden and the Netherlands. Paper presented at the improving global drug policy: comparative perspectives and UNGASS 2015, Washington DC, USA, 2015.
15. Chen, A. (2011, 01/06/2011). The underground website where you can buy any drug imaginable. Retrieved 27th of July, 2015, from http://gawker.com/the-underground-website-where-you-can-buy-any-drug-imag-30818160.
16. Chen, Z., Huang, K., Drug problems in China: Recent trends, countermeasures, and challenges. International Journal of Offender Therapy and Comparative Criminology 51:1 (2007), 98–109, 10.1177/0306624X06295717.
17. Christin, N., Traveling the Silk Road: A measurement analysis of a large anonymous online marketplace. Paper presented at the World Wide Web conference, Rio de Janeiro, Brazil, 2013 Working Paper retrieved from http://arxiv.org/abs/1207.7139.
18. Coomber, R., Moyle, L., Beyond drug dealing: Developing and extending the concept of ‘social supply’ of illicit drugs to ‘minimally commercial supply’. Drugs: Education, Prevention, and Policy 21:2 (2014), 157–164, 10.3109/09687637.2013.798265.
19. Dai, M., Gao, H., Drug users’ satisfaction with drug control by the Police in China. Asian Journal of Criminology 9:3 (2014), 205–219.
20. Davison, N., ‘Our purity is above 99%’: the Chinese labs churning out legal highs for the west. 2015 Retrieved 31st of August, 2015, from http://www.theguardian.com/society/2015/may/01/chinese-labs-legal-highs-west-drugs.
21. Décary-Hétu, D., Paquet-Clouston, M., Aldridge, J., Going international? Risk taking by cryptomarket drug vendors. International Journal of Drug Policy 35 (2016), 69–76.
22. Diamantopoulos, A., Schlegelmilch, B.B., Allpress, C., Export marketing research in practice: A comparison of users and non-users. Journal of Marketing Management 6:3 (1990), 257–273, 10.1080/0267257X.1990.9964131.
23. EMCDDA, European Union drug markets report: a strategic analysis., 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.
24. EMCDDA, European drug report., 2015, European Monitoring Centre for Drugs and Drug Addiction, Luxembourg.
25. Ensafi, R., Winter, P., Mueen, A., Crandall, J.R., Analyzing the Great Firewall of China over space and time. Proceedings on privacy enhancing technologies, Vol. 2015, 2015 pp. 61.
26. Gardiner, J.C., Luo, Z., Roman, L.A., Fixed effects, random effects and GEE: What are the differences?. Statistics in Medicine 28:2 (2009), 221–239, 10.1002/sim.3478.
27. Governing, State marijuana laws map. 2015 Retrieved 31st of August, 2015, from http://www.governing.com/gov-data/state-marijuana-laws-map-medical-recreational.html.
28. Hall, W., Weier, M., Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clinical Pharmacology & Therapeutics 97:6 (2015), 607–615, 10.1002/cpt.110.
29. Hernandez, S.H., Nelson, L.S., Prescription drug abuse: Insight into the epidemic. Clinical Pharmacology & Therapeutics 88:3 (2010), 307–317, 10.1038/clpt.2010.154.
30. Home Office, Drug misuse: findings from the 2014/15 crime survey for England and Wales statistical bulletin 03/15. 2015, Home Office, London.
31. Jones, C.M., Mack, K.A., Paulozzi, L.J., Pharmaceutical overdose deaths, United States, 2010. JAMA 309:7 (2013), 657–659, 10.1001/jama.2013.272.
32. Martin, J., Drugs on the dark net: how cryptomarkets are transforming the global trade in illicit drugs. 2014, Palgrave Pivot, New York.
33. National Institute on Drug Abuse, DrugFacts: nationwide trends from the National Survey on Drug Use and Health (NSDUH). 2015 Retrieved 29th of July, 2015, from http://www.drugabuse.gov/publications/drugfacts/nationwide-trends.
34. Sindicich, N., Burns, L., Australian trends in ecstasy and related drug markets 2011. Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trend Series No. 82., 2012, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
35. Sindicich, N., Burns, L., Australian trends in ecstasy and related drug markets 2014. Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trend Series No. 136., 2015, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
36. Smith, S., Garlich, F., Availability and supply of novel psychoactive substances. Dargan, P., Wood, D., (eds.) Novel psychoactive sustances: classification, pharmacology and toxicology, 2013, Elsevier Academic Press, Amsterdam, Netherlands.
37. Soska, K., Christin, N., Measuring the longitudinal evolution of the online anonymous marketplace ecosystem. Paper presented at the 24th USENIX security symposium, Washington, D.C., 2015.
38. Spapens, T., Müller, T., van de Bunt, H., The Dutch drug policy from a regulatory perspective. European Journal on Criminal Policy and Research 21:1 (2015), 191–205, 10.1007/s10610-014-9249-3.
39. Sun, H.-q., Bao, Y.-p., Zhou, S.-j., Meng, S.-q., Lu, L., The new pattern of drug abuse in China. Current Opinion in Psychiatry 27:4 (2014), 251–255, 10.1097/yco.0000000000000073.
40. The World Bank, Total population (in number of people). 2015 Retrieved 24th of July, 2015, from http://data.worldbank.org/indicator/SP.POP.TOTL.
41. United Nations Office on Drugs and Crime, World drug report 2014 (Vol. E.14. XI.7)., 2014, United Nations, Vienna, Austria.
42. Van Buskirk, J., Roxburgh, A., Bruno, R., Burns, L., Drugs and the Internet, Issue 1. 2013, National Drug and Alcohol Research Centre, Sydney, Australia.
43. Van Buskirk, J., Roxburgh, A., Bruno, R., Burns, L., Drugs and the Internet, Issue 2. 2014, National Drug and Alcohol Research Centre, Sydney, Australia.
44. Van Buskirk, J., Roxburgh, A., Bruno, R., Burns, L., Drugs and the Internet, Issue 3. 2014, National Drug and Alcohol Research Centre, Sydney, Australia.
45. Van Buskirk, J., Roxburgh, A., Bruno, R., Burns, L., Drugs and the Internet, Issue 4. 2015, National Drug and Alcohol Research Centre, Sydney, Australia.
46. Van Buskirk, J., Roxburgh, A., Naicker, S., Burns, L., A response to Dolliver's “Evaluating drug trafficking on the Tor network”. International Journal of Drug Policy 26:11 (2015), 1126–1127, 10.1016/j.drugpo.2015.07.001.
47. Van Hout, M.C., Bingham, T., ‘Surfing the Silk Road’: A study of users’ experiences. International Journal of Drug Policy 21 (2013), 359–363.
48. Van Hout, M.C., Bingham, T., Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. International Journal of Drug Policy 25:2 (2014), 183–189, 10.1016/j.drugpo.2013.10.009.
49. Walsh, C., Drugs, the Internet and change. Journal of Psychoactive Drugs 43:1 (2011), 55–63, 10.1080/02791072.2011.566501.
50. Whiteford, H.A., Degenhardt, L., Rehm, J., Baxter, A.J., Ferrari, A.J., Erskine, H.E., Vos, T., Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. The Lancet 382:9904 (2013), 1575–1586, 10.1016/s0140-6736(13)61611-6.
51. Whiteford, H.A., Ferrari, A.J., Degenhardt, L., Feigin, V., Vos, T., The global burden of mental, neurological and substance use disorders: An analysis from the Global Burden of Disease Study, 2010. PLoS One, 10(2), 2015, e0116820, 10.1371/journal.pone.0116820.
52. Winstock, A.R., The Global drug survey 2015 findings. 2015 Retrieved 19th of October, 2015, from http://www.globaldrugsurvey.com/the-global-drug-survey-2015-findings/.
53. Winstock, A. R., & Wilkins, C. (2011). ‘Legal Highs’: The Challenge of New Psychoactive Substances. TNI/IDPC Transnational Institute Series on Legislative Reform of Drug Policies (Vol. 16).